Skip to main content
Advertisement
Advertisement

DERM

DERM logo

Journey Medical Corporation Common Stock

6.50
USD
Sponsored
-0.75
-10.34%
Sep 23, 15:59 UTC -4
Closed
exchange

After-Market

6.50

0.00
0.00%

DERM Earnings Reports

Positive Surprise Ratio

DERM beat 7 of 19 last estimates.

37%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Journey Medical Corporation Common Stock earnings per share and revenue

On Aug 12, 2026, DERM reported earnings of -0.01 USD per share (EPS) for Q2 26, beating the estimate of -0.02 USD, resulting in a 56.33% surprise. Revenue reached 18.51 million, compared to an expected 18.73 million, with a -1.19% difference. The market reacted with a +3.42% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Journey Medical Corporation Common Stock reported EPS of -$0.01, beating estimates by 56.33%, and revenue of $18.51M, -1.19% below expectations.
The stock price moved up 3.42%, changed from $6.43 before the earnings release to $6.65 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Journey Medical Corporation Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement